-
KalVista Pharmaceuticals Announces European Commission and Swissmedic Approval of EKTERLY® (sebetralstat), First and Only Oral On-Demand Treatment for Hereditary Angioedema
22 Sep 2025 11:30 GMT
… treatment of acute attacks of hereditary angioedema (HAE) in adults and adolescents … ;391(1):32–43.
About Hereditary Angioedema
Hereditary angioedema (HAE) is a rare genetic … oral on-demand treatment for hereditary angioedema (HAE)—and continues to work …
-
New clinical trial offers hope for hereditary angioedema patients in Little Rock
20 Sep 2025 09:57 GMT
… offering hope to families battling hereditary angioedema (HAE), a rare and life … Dr. Sitz. He explained that hereditary angioedema is a genetic abnormality that …
-
KalVista Pharmaceuticals’ Hereditary Angioedema Drug Approved In EU, Switzerland: Retail Sees Stock Rallying To $22 In A Year
19 Sep 2025 21:52 GMT
… treatment of acute attacks of hereditary angioedema (HAE).
Ekterly was approved by … 10 years of market exclusivity.
Hereditary angioedema (HAE) is a rare genetic …
-
Intellia Therapeutics Completes Enrollment in the Global Phase 3 HAELO Study of Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema
18 Sep 2025 11:30 GMT
… z) for the treatment of hereditary angioedema (HAE). Topline data are … by the European Commission. About Hereditary Angioedema
Hereditary angioedema (HAE) is a rare, genetic … 2002) for the treatment of hereditary angioedema (“HAE”) pursuant to its clinical …
-
KalVista reports strong sales in early launch of hereditary angioedema drug
12 Sep 2025 11:19 GMT
KalVista Pharmaceuticals’ treatment for a rare disease that causes swelling attacks is enjoying a stronger-than-expected launch, but Wall Street analysts said continued momentum could depend …
-
Understanding the Unique Needs of Children Living with Hereditary Angioedema
09 Sep 2025 06:59 GMT
(BPT) - Hereditary angioedema (HAE) is a rare, inherited …
-
Lanadelumab beneficial no matter hereditary angioedema activity
02 Sep 2025 16:51 GMT
… four groups based on monthly hereditary angioedema attacks before lanadelumab.
Along … each group.
Patients with hereditary angioedema had lower attack rates, … colleagues evaluated 152 patients with hereditary angioedema (HAE) receiving lanadelumab (Takhzyro …
-
FDA approves donidalorsen for hereditary angioedema
26 Aug 2025 21:20 GMT
… medicine approved for patients with hereditary angioedema.
Editor’s note: This is … least 12 years to prevent hereditary angioedema attacks, according to a press … medicine approved for patients with hereditary angioedema (HAE).
According to the release …
-
FDA approves first RNA-targeted therapy for hereditary angioedema
22 Aug 2025 22:05 GMT
… for prophylaxis to prevent hereditary angioedema (HAE) attacks in … of the US Hereditary Angioedema Association and Hereditary Angioedema International.
Marc Riedl … -targeted prophylactic treatment for hereditary angioedema. Ionis Pharmaceuticals. August 21 …
-
FDA Approves First RNA-Targeted Treatment for Hereditary Angioedema
22 Aug 2025 18:57 GMT
… RNA-targeted prophylactic treatment for hereditary angioedema. News release. Business Wire. … RNA-targeted-prophylactic-treatment-for-hereditary-angioedema
2. Riedl MA, … .1056/NEJMoa2402478
3. Hereditary angioedema. Cleveland Clinic. Updated March …
About
© 1995-2025